News
Public · Published
TD Cowen maintains Aptiv at Buy, lowers price target to $72 from $77
TD Cowen kept its Buy rating on Aptiv but cut its price target, its estimate of a possible future share price, to $72 from $77, a 6.5% decrease. The article says the new target implies 74.2% upside from Aptiv's Nov. 3 closing price of $41.34.
Published:
Updated:
What happened
TD Cowen kept its Buy rating on Aptiv but cut its price target, its estimate of a possible future share price, to $72 from $77, a 6.5% decrease. The article says the new target implies 74.2% upside from Aptiv’s Nov. 3 closing price of $41.34.
Confirmed
Global impact / market context
The lower target signals that TD Cowen has become less optimistic about Aptiv’s potential share price, even while retaining its Buy rating. The target is an analyst estimate, not a company forecast or a guarantee, so it does not itself change Aptiv’s revenue, costs, or cash available.
Analyst inference
The article lists five other recent Aptiv price targets, ranging from $45 to $64, all below TD Cowen’s new $72 target. That comparison shows a wide gap between analysts’ estimates, but does not establish which estimate is more accurate or how investors will respond.
Confirmed
What to watch
- Compare later Aptiv analyst updates with TD Cowen’s $72 target and the listed $45–$64 range to see whether estimates converge or diverge further. Analyst inference
- Watch for company information on sales, costs, or cash available; the article provides no operating results that explain TD Cowen’s target reduction. Analyst inference
- The article reports that TD Cowen maintained its Buy rating while lowering its target from $77 to $72, a 6.5% decrease. Confirmed
Evidence
- Original source link unavailable